ENGYSTOL- cynanchum vincetoxicum root and sulfur injection

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

CYNANCHUM VINCETOXICUM ROOT (UNII: 9R858U917W) (CYNANCHUM VINCETOXICUM ROOT - UNII:9R858U917W), SULFUR (UNII: 70FD1KFU70) (SULFUR - UNII:70FD1KFU70)

Available from:

MediNatura

INN (International Name):

CYNANCHUM VINCETOXICUM ROOT

Composition:

CYNANCHUM VINCETOXICUM ROOT 6 [hp_X] in 1.1 mL

Administration route:

INTRADERMAL

Prescription type:

PRESCRIPTION DRUG

Therapeutic indications:

Engystol® Injection Solution is a homeopathic drug product indicated for the support of the immune system to reduce severity and duration of symptoms in viral infections, particularly in the early stages of colds and influenza-like illnesses. Engystol® Injection Solution is contraindicated in patients with known hypersensitivity to Engystol® or any of its ingredients.

Authorization status:

unapproved homeopathic

Summary of Product characteristics

ENGYSTOL- CYNANCHUM VINCETOXICUM ROOT AND SULFUR INJECTION
MEDINATURA
_Disclaimer: This homeopathic product has not been evaluated by the
Food and Drug_
_Administration for safety or efficacy. FDA is not aware of scientific
evidence to support_
_homeopathy as effective._
----------
ENGYSTOL 1.1ML INJECTION
DESCRIPTION
Ingredient name
Potency Quantity Final dilution
Asclepias vincetoxicum 6X
6.6 μl
8.22X
Asclepias vincetoxicum 10X
6.6 μl
12.22X
Asclepias vincetoxicum 30X
6.6 μl
32.22X
Sulphur
4X
3.3 μl
6.52X
Sulphur
10X
3.3 μl
12.52X
INDICATIONS AND USAGE
Engystol® Injection Solution is a homeopathic drug product indicated
for the support of
the immune system to reduce severity and duration of symptoms in viral
infections,
particularly in the early stages of colds and influenza-like
illnesses.
DOSAGE AND ADMINISTRATION
GENERAL CONSIDERATIONS
• The dosage schedules listed below can be used as a general guide
for the
administration of Engystol
Injection Solution.
• Engystol
Injection Solution may be administered s.c., i.d., i.m., or i.v.
• The interval between injections is left to the discretion of the
HCP, but should not
exceed 1 ampule in 24 hours.
• Parenteral drug products should be inspected visually for
particulate matter and
discoloration prior to administration, whenever solution and container
permit. Discard
any unused ampule contents.
• Draw up required dose into syringe.
• Discard any unused ampule contents. Do not reuse ampule.
Only licensed practitioners with sufficient expertise in injecting
drugs, including the
respective route of administration, should administer the product.
STANDARD DOSAGE:
ADULTS AND CHILDREN 12 YEARS AND OLDER: 1 ml 1 to 3 times per 7 days.
®
®
CHILDREN 6 TO 11 YEARS: 0.7 ml 1 to 3 times per 7 days.
CHILDREN 2 TO 5 YEARS: 0.5 ml 1 to 3 times per 7 days.
ACUTE DOSAGE:
ADULTS AND CHILDREN 12 YEARS AND OLDER: 1 ml daily, and then continue
with standard
dosage.
CHILDREN 6 TO 11 YEARS: 0.7 ml daily, and then continue with standard
dosage.
CHILDREN 2 TO 5 YEARS: 0.